CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2019
Jun. 30, 2019
ASSETS    
Cash $ 187,000 $ 579,000
Prepaid expenses and other current assets 29,000 46,000
Total Current Assets 216,000 625,000
Other Assets:    
Patent costs - net 3,201,000 3,342,000
Property, plant and equipment -net 1,000
Security deposit 78,000 78,000
Total Other Assets 3,279,000 3,421,000
Total Assets 3,495,000 4,046,000
Current Liabilities:    
Accounts payable - (including related party payables of approx. $1,511,000 and $1,511,000, respectively) 2,285,000 2,127,000
Accrued expenses - (including related party accruals of approx. $75,000 and $45,000, respectively) 120,000 85,000
Accrued salaries and payroll taxes -(including related party accrued salaries of approx. $3,282,000 and $3,129,000, respectively) 3,358,000 3,162,000
Operating lease current liability 126,000
Note payable - related party 1,922,000 1,922,000
Total Current Liabilities 7,811,000 7,296,000
Series B 5% convertible preferred stock liability at $1,080 stated value; 1,440 and 1,196 shares issued and outstanding at December 31, 2019 and June 30, 2019, respectively 812,000 879,000
Operating lease long term liability 489,000
Total Liabilities 9,112,000 8,175,000
Commitments and contingencies (Note 9)
Stockholders' Deficiency    
Preferred stock, $0.001 par value, 10,000,000 designated shares, no shares issued and outstanding
Additional paid-in capital 93,278,000 90,537,000
Accumulated deficit (98,771,000) (94,596,000)
Treasury Stock, at cost (659,448 shares and 228,218 shares as of December 31, 2019 and June 30, 2019, respectively) (146,000) (91,000)
Total Stockholders' Deficiency (5,617,000) (4,129,000)
Total Liabilities and Stockholders' Deficiency 3,495,000 4,046,000
Common Class B [Member]    
Stockholders' Deficiency    
Common Stock - Class B, (10 votes per share); $.0001 par value, 100,000,000 shares authorized, 909,090 shares and 909,090 shares issued and outstanding as of December 31, 2019 and June 30, 2019, respectively
Common Class A [Member]    
Stockholders' Deficiency    
Common Stock - Class A, $0.0001 par value, 600,000,000 shares and 300,000,000 shares authorized, as of December 31, 2019 and June 30, 2019, respectively, 219,211,111 shares and 202,860,141 shares issued as of December 31, 2019 and June 30, 2019, respectively, 218,551,663 shares and 202,631,923 shares outstanding as of December 31, 2019 and June 30, 2019, respectively $ 22,000 $ 21,000